INCR's logo.
Ticker Symbol: INCR

Intercure Ltd

$7.81 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001857030

Company Profile

intercure (dba canndoc) (nasdaq: incr) (tsx: incr.u) (tase: incr) is the leading, profitable, and fastest growing cannabis company outside of north america. canndoc, a wholly owned subsidiary of intercure, is israel’s largest licensed cannabis producer and one of the first to offer good manufacturing practices (gmp) certified and pharmaceutical-grade medical cannabis products. intercure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of north america. for more information, visit: http://www.intercure.co.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: intercure.co
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.62
Change: $0.08 ( 5.20%)
Days Range: $1.50 - $1.62
Beta: 0.95
52wk. High: $5.56
52wk. Low: $1.15
Ytd. Change -48.14%
50 Day Moving Average: $1.52
200 Day Moving Average: $1.82
Shares Outstanding: 45133964

Valuation

Market Cap: 7.3B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A